由于可负担得起的高质量护理和新的国际卫生伙伴关系,印度成为全球医疗旅行的最高目的地。 India emerges as top global medical travel destination due to affordable, high-quality care and new international health partnerships.

在新德里发表的一份新白皮书突显了印度在全球医疗旅行中不断上升的作用,其驱动力是高成本和西方国家漫长的等待时间。 A new white paper released in New Delhi highlights India’s rising role in global medical travel, driven by high costs and long wait times in Western nations. 它将印度定位为成本效益高、高质量的替代办法,其程序成本比美国和欧洲低40-90%。 It positions India as a cost-effective, high-quality alternative, with procedures costing 40–90% less than in the U.S. and Europe. 印度主要医院在心脏病科、矫形科和肿瘤科的高级护理方面得到承认,并得到了Ayurveda等技术和整体健康服务的支持。 Leading Indian hospitals are recognized for advanced care in cardiology, orthopedics, and oncology, supported by technology and holistic wellness offerings like Ayurveda. 报告呼吁在TMTC全套平台的推动下,建立结构化、由医生主导的医疗旅行系统,具有透明的定价、经认可的设施和无缝善后护理。 The report calls for a structured, doctor-led medical travel system with transparent pricing, accredited facilities, and seamless aftercare, promoted by TMTC’s full-stack platform. 这次活动使全球卫生领导人和大使聚集一堂,以加强国际医疗走廊。 The event brought together global health leaders and ambassadors to strengthen international medical corridors.